Bleeding Disorders

George King Bio-Medical, Inc. and NBDF History

Posted on

Last summer, we were visited by the National Bleeding Disorders Foundation. They are celebrating 75 years the same year we are celebrating our 50th! Since our beloved founder, George King, was a 2 term president, the NHF (now NBDF) wanted to make sure our company was included not only on their 75 year timeline, but   …Continue Reading


Unite For Bleeding Disorders Walk 2022

Posted on

Unite for Bleeding Disorders Walk through Midwest Hemophilia Association  George King Bio-Medical, Inc.  News Release OLATHE, Kan.- This past Saturday June 11, employees from George King Bio-Medical Inc. represented the company at the annual local chapter Midwest Hemophilia Association Unite for Bleeding Disorder Walk. The walk is held each year to support individuals with bleeding disorders.   …Continue Reading


Q&A with Chris Bombardier

Posted on

Q: Our audience is primarily Laboratory Professionals, what message you would have for them? A: I actually started my career working in a hemophilia research lab where I enjoyed learning more of the scientific aspect of the disease. I still miss working in the lab, factor assays were my favorite part. They were like a puzzle and   …Continue Reading


Have You Heard the New Musical Group King?

Posted on

Is this the real thing? It’s not lyophilized….


Fresh Frozen Plasma vs Lyophilized: What should your lab use?

Posted on

Coagulation laboratories have a variety of choices for reagents.  What are the differences and why are they important? Fresh frozen reagents are collected from the donor and frozen immediately.  After thawing, they require no preparation, thaw and go. Lyophilization is the process of freeze drying a reagent to remove the liquid component. The process leaves   …Continue Reading


Factor Sensitivities – What’s the value, anyway? [Pun intended]

Posted on

Currently the global test used to detect intrinsic factor deficiencies in patients with bleeding is the activated partial thromboplastin time (APTT). The APTT reagent used should be sensitive to a reduction in coagulation factors such as FVIII and FIX that are commonly associated with bleeding. Literature states that it is desirable to have APTT systems   …Continue Reading


Von Willebrand Disease: The 4 minute overview [with images]

Posted on

Von Willebrand Disease (VWD) is a genetic disorder caused by missing or defective von Willebrand factor (VWF), a clotting protein. VWF binds factor VIII, a key clotting protein, and platelets in blood vessel walls, which help form a platelet plug during the clotting process. [1] History of the disease  The first written piece describing this inherited   …Continue Reading